DOCSLIB.ORG

Erik Senneby Kappa

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Erik Senneby Kappa Aerococcal infections - from bedside to bench and back Senneby, Erik 2018 Document Version: Förlagets slutgiltiga version Link to publication Citation for published version (APA): Senneby, E. (2018). Aerococcal infections - from bedside to bench and back. Lund University: Faculty of Medicine. Total number of authors: 1 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Aerococcal infections - from bedside to bench and back Erik Senneby DOCTORAL DISSERTATION by due permission of the Faculty of Medicine, Lund University, Sweden. To be defended at Segerfalkssalen, BMC, on May 24th 2018 at 13.00. Faculty opponent Associate professor Christian Giske Karolinska Institutet 1 Organization Document name LUND UNIVERSITY Doctoral dissertation Department of Clinical Sciences Date of issue Division of Infection Medicine 20180524 Author(s) Erik Senneby Sponsoring organization Title and subtitle Aerococcal Infections – from bedside to bench and back Abstract The genus Aerococcus comprises eight species of Gram-positive cocci. Due to difficulties in species identification of aerococci in the past, the incidence and clinical importance of aerococcal infections has been underestimated. We evaluated the usefulness of MALDI- TOF MS as a species identification method for aerococci and found that it had a high sensitivity and specificity. Two population-based studies on aerococcal bacteruria were performed. A. urinae and A. sanguinicola were isolated in approximately 1 % of all urine samples in Skåne. The patients were of old age and gender was almost equally distributed between men and women. Almost 80 % of patients with aerococcal bacteruria had symptoms of a urinary tract infection. Several antibiotics, including nitrofurantoin and amoxicillin, could serve as treatment options. Resistance against ciprofloxacin was recorded, especially in A. sanguinicola isolates. In a retrospective population-based study on aerococcal bacteremia, 77 patients were identified during a three-year period (A. urinae n=49, A. sanguinicola n=13, A. viridans n=14 and A. christensenii n=1). The A. urinae and A. sanguinicola patients were old (median age >80 years), predominately of male gender and underlying urological diseases were common. A majority of the A. urinae and A. sanguinicola patients had severe sepsis. Five patients with A. urinae bacteremia were diagnosed with infective endocarditis. A. viridans seemed to be a contaminant in most cases. The aerococcal isolates were sensitive to betalactam antibiotics and vancomycin. Two studies were conducted regarding virulence mechanisms. We demonstrated that A. sanguinicola isolates produced biofilm and activated platelets, two potentially important virulence factors. A. urinae isolates were subjected to masspectrometry-based proteomics and whole genome sequencing. Two cell wall-anchored proteins with LPXTG-motifs, with unknown functions, dominated the surface and genes encoding these proteins were localized in a conserved locus on the aerococcal chromosome. Key words: Aerococcus, bacteremia, urinary tract infections, MALDI-TOF MS, surface proteome, genes encoding surface proteins Classification system and/or index terms (if any) Supplementary bibliographical information Language English ISSN and key title 1652-8220 ISBN 978-91-7619-640-3 Recipient’s notes Number of pages Price Security classification I, the undersigned, being the copyright owner of the abstract of the above-mentioned dissertation, hereby grant to all reference sources permission to publish and disseminate the abstract of the above-mentioned dissertation. Signature Date 2 Aerococcal infections - from bedside to bench and back Erik Senneby 3 Erik Senneby Division of Infection Medicine Department of Clinical Sciences Faculty of Medicine Lund University Biomedical Center, B14 Tornavägen 10 221 84 Lund Sweden Email: [email protected] Cover picture by Erik Senneby Copyright Erik Senneby Paper I is reprinted by permission from the American Society for Microbiology Paper II is reprinted by permission from Oxford University Press Paper III is reprinted by permission from Springer Paper IV-V is reprinted by permission from Elsevier Faculty of Medicine Department of Clinical Sciences, Lund ISBN 978-91-76-19-640-3 ISSN 1652-8220 Printed in Sweden by Media-Tryck, Lund University Lund 2018 WAN E S CO IC L D A B R E O L N Media-Tryck is an environmentally certified and ISO 14001 certified 1234 5678 provider of printed material. Read more about our environmental work at www.mediatryck.lu.se 4 5 Table of Contents List of papers ............................................................................................... 8 Abbrevations.............................................................................................. 10 Abstract ...................................................................................................... 11 Aims with the thesis .................................................................................. 13 Aerococci – emerging pathogens? .............................................................. 14 1. Introduction to Aerococcus .................................................................. 17 2. A historical overview of the genus Aerococcus. .................................. 19 Taxonomic confusion and dead lobsters. .......................................... 19 Aerococcus-like organisms and human disease................................. 20 … and additional aerococcal species ................................................. 21 3. Methods in clinical bacteriology .......................................................... 23 Gram staining .................................................................................... 23 MALDI-TOF MS .............................................................................. 24 Urine culture procedures ................................................................... 25 Blood culture procedures ................................................................... 28 4. Species identification of aerococci ....................................................... 29 5. Clinical presentation of aerococcal bacteriuria.................................. 33 6. Clinical presentation of invasive aerococcal infections. .................... 37 7. Aerococcal antibiotic susceptibility. .................................................... 41 Synergistic effects of antibiotic combinations................................... 45 Antibiotic resistance mechanisms in aerococci ................................. 45 8. Virulence mechanisms and aerococci .................................................. 49 Bacterial induced platelet aggregation .............................................. 49 Biofilm formation .............................................................................. 50 Cell wall-anchored proteins with an LPXTG-motif .......................... 51 6 9. Present investigations. .......................................................................... 53 Paper I ................................................................................................ 53 Paper II .............................................................................................. 54 Paper III ............................................................................................. 55 Paper IV ............................................................................................. 56 Paper V .............................................................................................. 58 Paper VI ............................................................................................. 59 10. Conclusion and future perspectives................................................... 61 The incidence increase....................................................................... 61 Clinical significance .......................................................................... 62 Urinary tract infections .............................................................. 62 Invasive infections ..................................................................... 63 Male dominance ........................................................................ 63 Treatment of aerococcal infections.................................................... 64 Virulence mechanisms and aerococci................................................ 64 Finally, is there a human aerococcal habitat? .................................... 66 Populärvetenskaplig sammanfattning på svenska ................................. 67 Acknowledgements...................................................................................
Load more

Recommended publications
  • ( 12 ) United States Patent
    US009956282B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,956 , 282 B2 Cook et al. (45 ) Date of Patent: May 1 , 2018 ( 54 ) BACTERIAL COMPOSITIONS AND (58 ) Field of Classification Search METHODS OF USE THEREOF FOR None TREATMENT OF IMMUNE SYSTEM See application file for complete search history . DISORDERS ( 56 ) References Cited (71 ) Applicant : Seres Therapeutics , Inc. , Cambridge , U . S . PATENT DOCUMENTS MA (US ) 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al . 3 , 228 , 838 A 1 / 1966 Rinfret (72 ) Inventors : David N . Cook , Brooklyn , NY (US ) ; 3 ,608 ,030 A 11/ 1971 Grant David Arthur Berry , Brookline, MA 4 ,077 , 227 A 3 / 1978 Larson 4 ,205 , 132 A 5 / 1980 Sandine (US ) ; Geoffrey von Maltzahn , Boston , 4 ,655 , 047 A 4 / 1987 Temple MA (US ) ; Matthew R . Henn , 4 ,689 ,226 A 8 / 1987 Nurmi Somerville , MA (US ) ; Han Zhang , 4 ,839 , 281 A 6 / 1989 Gorbach et al. Oakton , VA (US ); Brian Goodman , 5 , 196 , 205 A 3 / 1993 Borody 5 , 425 , 951 A 6 / 1995 Goodrich Boston , MA (US ) 5 ,436 , 002 A 7 / 1995 Payne 5 ,443 , 826 A 8 / 1995 Borody ( 73 ) Assignee : Seres Therapeutics , Inc. , Cambridge , 5 ,599 ,795 A 2 / 1997 McCann 5 . 648 , 206 A 7 / 1997 Goodrich MA (US ) 5 , 951 , 977 A 9 / 1999 Nisbet et al. 5 , 965 , 128 A 10 / 1999 Doyle et al. ( * ) Notice : Subject to any disclaimer , the term of this 6 ,589 , 771 B1 7 /2003 Marshall patent is extended or adjusted under 35 6 , 645 , 530 B1 . 11 /2003 Borody U .
    [Show full text]
  • Full Text in Pdf Format
    DISEASES OF AQUATIC ORGANISMS Vol. 3: 97-100, 1987 Published December 14 Dis. aquat. Org. l Screening of Norwegian lobsters Homarus gammarus for the lobster pathogen Aerococcus virid ans Ragnhild wiikl, Emmy Egidiusl, Jostein ~oksayr~ ' Institute of Marine Research, Directorate of Fisheries, PO Box 2906, N-5011 Bergen-Nordnes. Norway ' Department of Microbiology and Plant Physiology. University of Bergen. N-5014 Bergen-University, Norway ABSTRACT: Hemolymph samples drawn from 3044 lobsters trapped along the southwestern part of the Norwegian coast in the period 1981 to 1984 were individually examined for Aerococcus viridans, the causative agent of gaffkemia. In 1981, one of 779 hemolymph samples was positive with respect to the bacterium. During the period 1982 to 1984, 2265 lobsters were examined and found negative for A. viridans. These results, together with the fact that gaffkemia has not been reported in the region since 1980, suggest that the disease is not enzootic in these waters. Because of the high survival capacity of the lobster pathogen, strong measures with respect to disinfection of ponds and tanks are recom- mended following outbreaks of gaffkemia. INTRODUCTION Kvits~y,an island situated about 25 km northwest of Stavanger. Mortalities among the imported lobsters, Gaffkemia is an infection of lobsters caused by the however, continued, and gaffkemia was diagnosed as bacterium Aerococcus viridans (Evans 1974). The dis- the cause (Hbstein et al. 1977). ease can cause heavy mortalities among both Homarus New outbreaks of gaffkemia occurred in Stavanger americanus H. Milne Edwards 1837 and H, gammarus and at Kvits~yIn 1977 and 1980; all 6 ponds in the area L.
    [Show full text]
  • (Var.) Homari, Pathogen of Homarid Lobsters
    DISEASES OF AQUATIC ORGANISMS Vol. 13: 133-138.1992 Published July 23 Dis. aquat. Org. Evaluation of an indirect fluorescent antibody technique for detection of Aerococcus viridans (var.)homari, pathogen of homarid lobsters L. J. ~arks',James E. stewart', Tore ~istein~ ' Department of Fisheries and Oceans, Biological Sciences Branch. Bedford Institute of Oceanography, PO Box 1006, Dartmouth, Nova Scotia. Canada B2Y 4A2 * The National Veterinary Institute, PO Box 8156. Dept. 0033. Oslo 1, Norway ABSTRACT: Application of an indirect fluorescent antibody technique (IFAT) significantly shortened the time required for detection and identification of the lobster pathogen Aerococcus viridans (var.) homan, from culture media or directly from lobster hemolymph. The normal 4 to 7 d for confirmed diagnoses using traditional bacteriological procedures was reduced to 2 h for detection of heavy infections, or 48 to 50 h when amplification of numbers was required. Of the bacteria checked, only Staphylococcus aureus cross-reacted; this was overcome by treatment of fixed slides with papain prior to IFA staining. The validity of the method was confirmed in comparisons between the traditional procedures and IFAT using samples from 1090 lobsters which had shown presumptive signs of infection. INTRODUCTION fluorescent antibody technique (IFAT); this paper describes its evaluation and application, plus validation Gaffkemia, the fatal disease of lobsters (genus through field comparisons involving samples from 1090 Homarus), caused by the bacterium Aerococcus vir- lobsters showing presumptive signs of infection. idans (var.) homari, is responsible, periodically, for heavy mortalities among captive homarid lobsters (Snieszko & Taylor 1947, Stewart et al. 1975, Hastein et MATERIALS AND METHODS al. 1977, Stewart 1980, Gjerde 1984).
    [Show full text]
  • Risk Assessment of American Lobster (Homarus Americanus)
    Risk assessment of American lobster (Homarus americanus) Swedish Agency for Marine and Water Management Report 2016:4 Risk assessment of the American lobster (Homarus americanus) Swedish Agency for Marine and Water Management Swedish Agency for Marine and Water Management Date: 2016-07-29 (updated version) Publisher: Björn Sjöberg Cover page photo: Vidar Öresland ISBN 978-91-87967–09-2 Havs- och vattenmyndigheten Box 11930, 404 39 Göteborg www.havochvatten.se Risk assessment of the American lobster (Homarus americanus) Swedish Agency for Marine and Water Management Risk assessment of American lobster (Homarus americanus) Swedish Agency for Marine and Water Management Report 2016:4 Risk assessment of the American lobster (Homarus americanus) Swedish Agency for Marine and Water Management Preamble American lobster (Homarus americanus) Pest Risk Assessment has been produced following the scheme: GB non-native organism risk assessment scheme, version 5 which was prepared by CABI Bioscience (CABI), Centre for Environment, Fisheries and Aquaculture Science (CEFAS), Centre for Ecology and Hydrology (CEH), Central Science Laboratory (CSL), Imperial College London (IC) and the University of Greenwich (UoG). The pest risk assessment scheme constructed by the European and Mediterranean Plant Protection Organisation (EPPO, 1997 and in prep.) provided the basis for the Great Britain NonNative Organism Risk Assessment scheme. The EPPO scheme closely follows the international standard for phytosanitary measures (ISPM 11) on pest risk analysis produced by the International Plant Protection Convention (IPPC) (FAO, 2003). IPPC standards are recognised by the Sanitary and Phytosanitary Agreement of the World Trade Organization (WTO, 1994). More information on the scheme is provided at www.nonnativespecies.org/downloadDocument.cfm?id=158.
    [Show full text]
  • Depression and Microbiome—Study on the Relation and Contiguity Between Dogs and Humans
    applied sciences Article Depression and Microbiome—Study on the Relation and Contiguity between Dogs and Humans Elisabetta Mondo 1,*, Alessandra De Cesare 1, Gerardo Manfreda 2, Claudia Sala 3 , Giuseppe Cascio 1, Pier Attilio Accorsi 1, Giovanna Marliani 1 and Massimo Cocchi 1 1 Department of Veterinary Medical Science, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Italy; [email protected] (A.D.C.); [email protected] (G.C.); [email protected] (P.A.A.); [email protected] (G.M.); [email protected] (M.C.) 2 Department of Agricultural and Food Sciences, University of Bologna, Via del Florio 2, 40064 Ozzano Emilia, Italy; [email protected] 3 Department of Physics and Astronomy, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-051-209-7329 Received: 22 November 2019; Accepted: 7 January 2020; Published: 13 January 2020 Abstract: Behavioral studies demonstrate that not only humans, but all other animals including dogs, can suffer from depression. A quantitative molecular evaluation of fatty acids in human and animal platelets has already evidenced similarities between people suffering from depression and German Shepherds, suggesting that domestication has led dogs to be similar to humans. In order to verify whether humans and dogs suffering from similar pathologies also share similar microorganisms at the intestinal level, in this study the gut-microbiota composition of 12 German Shepherds was compared to that of 15 dogs belonging to mixed breeds which do not suffer from depression. Moreover, the relation between the microbiota of the German Shepherd’s group and that of patients with depression has been investigated.
    [Show full text]
  • Roles of the Vagina and the Vaginal Microbiota in Urinary Tract Infection: Evidence from Clinical Correlations and Experimental Models
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 1-1-2020 Roles of the vagina and the vaginal microbiota in urinary tract infection: Evidence from clinical correlations and experimental models Amanda L Lewis Nicole M Gilbert Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Urogenital infections and inflammations OPEN ACCESS Review Article Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models Abstract Mounting evidence indicates that the vagina can harbor uropathogenic Amanda L. Lewis1,2,3 bacteria. Here, we consider three roles played by the vagina and its Nicole M. Gilbert2,3,4 bacterial inhabitants in urinary tract infection (UTI) and urinary health. First, the vagina can serve as a reservoir for Escherichia coli, the most common cause of UTI, and other recognized uropathogens. Second, 1 Molecular Microbiology, several vaginal bacterial species are frequently detected upon urine Washington University School culture but are underappreciated as uropathogens, and other vaginal of Medicine in Saint Louis, species are likely under-reported because of their fastidious nature. United States Third, some vaginal bacteria that are not widely viewed as uropathogens 2 Obstetrics and Gynecology, can transit briefly in the urinary tract, cause injury or immunomodulation, Washington University School and shift the balance of host-pathogen interactions to influence the of Medicine in Saint Louis, outcomes of uropathogenesis. This chapter describes the current liter- United States ature in these three areas and summarizes the impact of the vaginal 3 Center for Women's microbiota on susceptibility to UTI and other urologic conditions.
    [Show full text]
  • Benefits and Limitations of MALDI-TOF Mass Spectrometry for the Identification of Microorganisms
    Rychert J. Commentary: Benefits and Limitations of MALDI-TOF Mass Spectrometry for the Identification of Microorganisms. J Infectiology. 2019; 2(4): 1-5 Journal of Journal of Infectiology Infectiology Mini Review Open Access Benefits and Limitations of MALDI-TOF Mass Spectrometry for the Identification of Microorganisms Jenna Rychert ARUP Laboratories, Salt Lake City, Utah, USA Article Info Abstract Article Notes Matrix-assisted laser desorption-ionization time of flight mass spectrometry Received: April 19, 2019 (MALDI-TOF MS) is replacing traditional methods for identifying microorganisms Accepted: July 2, 2019 in the clinical laboratory. This relatively simple technique overcomes many of *Correspondence: the challenges of identifying bacteria and fungi. As the technology has evolved, Jenna Rychert, ARUP Laboratories, Salt Lake City, Utah, the expansion of the databases containing spectra of known organisms has USA; Email: [email protected]. allowed for the identification of species with similar phenotypic, genotypic, and biochemical properties that was not previously possible. This has resulted © 2019 Rychert J. This article is distributed under the terms of in improvements in clinical care including improving the diagnosis of infections the Creative Commons Attribution 4.0 International License. caused by relatively rare species and decreasing the time to diagnosis. In Keywords: many cases, this leads to a reduction in the time to appropriate therapy and Mass spectrometry even a decrease in the length of hospital stays. However, it is not without its MALDI-TOF MS limitations. Inherent similarities between organisms and a limited number of Bacteria spectra in the database can lead to poor discrimination between species, as Yeast Mycobacteria well as misidentifications.
    [Show full text]
  • A Thesis Submitted by for the Degree of in the UNIVERSITY of LONDON
    1 THE CLASSIFICATION OF STREPTOCOCCAL STRAINS A thesis submitted by GEOFFREY COLMAN for the degree of DOCTOR OF PHILOSOPHY in the UNIVERSITY OF LONDON Department of Bacteriology, Wright-Fleming Institute, St..Mary's Hospital Medical School, Paddington, London, W.2. February 1970 2 Abstract Three hundred and sixty-four strains of strepto- cocci were examined using standard serological methods with 23 different sera and by more than 40 different cultural and physiological tests. The cell wall constituents of 232 of these strains were determined and the data from 216 strains were examined by numerical methods using three computer programmes that formed clusters in different ways. Some species that have been formed in the past by conventional methods were seen to be satisfactory and these were: Streptococcus pyogenes, S. airalactiae,m S. ecLuisimilis, S. faecalis, S. faecium, S. bovis, S. uberis, the haemolytic i large-colony' strains of Lancefield group G, S. salivarius, S. lactic, S. cremoris, S. pneumoniae and S. mutans. The definitions of S. milleri, S. sanpuis and S. mitior have been amended and many streptococci that in the past would have been classed as I viridans-like' were assigned to one or other of these aggregated species. The validity of the species S. milleri, S. sanuis and S. mitior were tested by performing transformation reactions between 14 strains allotted to one or other of these species. The numbers of recombinants produced in these experiments were greater in intra- specific reactions than in inter-specific reactions. Some taxa, descriptions of which are available in the literature, were not represented among the newly isolated strains.
    [Show full text]
  • Human Mitochondrial DNA and Endogenous Bacterial Surrogates for Risk Assessment of Graywater Reuse
    Human Mitochondrial DNA and Endogenous Bacterial Surrogates for Risk Assessment of Graywater Reuse A thesis submitted to the College of Engineering in partial fulfillment of the requirements for the Degree of Master of Science in Environmental Science From the Department of Environmental Engineering School of Energy, Environment, Medical and Biological Engineering March 24, 2014 By Brian D. Zimmerman Bachelor of Science, University of Cincinnati (2011) Advisor and Committee Chair: Dr. David Wendell Abstract Groundwater aquifers and surface waters currently used as drinking water and irrigation sources are in danger of over exploitation, leading to potable water scarcity in many regions of the world. On-site treatment and reuse of recycled wastewaters such as graywater for non- potable purposes has the ability to enhance water sustainability by alleviating demands on potable water supplies, which is particularly valuable in arid regions or in times of severe draught. However, given the inevitable downstream human contact, graywater represents a waterborne pathogen transmission and amplification pathway if human exposure to reused water is practiced without adequate treatment. Enteric pathogens are currently thought to be one of the most significant public health risks to water reuse. (1) Thus, previous studies sought to predict enteric pathogen presence in graywater through the use of fecal indicator bacteria (FIB) to indicate human fecal contamination and possible pathogen presence. However, FIB are known to grow in stored graywater, (2) do not correlate well with pathogens, (3) and may not accurately predict risks from pathogens transmitted via respiratory/oral and dermal pathways. (4) Therefore, new metrics to measure and predict microbial risk in graywater recycling systems is necessary for advancement of these systems.
    [Show full text]
  • Genetic Characterization of the Lobster Pathogen Aerococcus Viridans Var. Homari by 16S Rrna Gene Sequence and RAPD
    DISEASES OF AQUATIC ORGANISMS Vol. 63: 237–246, 2005 Published February 28 Dis Aquat Org Genetic characterization of the lobster pathogen Aerococcus viridans var. homari by 16S rRNA gene sequence and RAPD Spencer J. Greenwood*, Ian R. Keith, Béatrice M. Després, Richard J. Cawthorn AVC Lobster Science Centre, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island C1A 4P3, Canada ABSTRACT: A combination of 16S rRNA sequencing and random amplified polymorphic DNA (RAPD) analysis was used to evaluate the genetic diversity within Aerococcus viridans var. homari, the causative agent of gaffkemia in lobsters. A collection of 7 A. viridans var. homari strains and 2 avirulent A. viridans-like cocci isolated from homarid lobsters harvested from different regions on the Atlantic Coast of North America were analyzed. The isolates are separated geographically and tem- porally between the years 1947 and 2000. Sequencing of 16S rRNA genes confirmed the inclusion of all 9 isolates in the monophyletic A. viridans clade (99.8 to 100% similarity). RAPD analysis revealed that the 9 A. viridans var. homari isolates could be separated into 2 distinct subtypes. Subtype 1 included the 7 pathogenic lobster isolates and constituted a homogeneous group regardless of their geographical, temporal or virulence differences. Subtype 2 contained the 2 avirulent A. viridans-like cocci that had distinct RAPD patterns and clustered separately with the non-marine A. viridans. RAPD analysis represented a useful method for determining molecular subtyping for the intraspecific classification and epidemiological investigations of A. viridans var. homari. KEY WORDS: Lobster · Homarus americanus · Gaffkemia · Aerococcus viridans var.
    [Show full text]
  • Aerococcus Urinae and Globicatella Sanguinis
    BCI0010.1177/1178626419875089Biochemistry InsightsYu et al 875089research-article2019 Advances in Tumor Virology Aerococcus urinae and Globicatella sanguinis Persist in Volume 12: 1–15 © The Author(s) 2019 Polymicrobial Urethral Catheter Biofilms Examined in Article reuse guidelines: sagepub.com/journals-permissions Longitudinal Profiles at the Proteomic Level DOI:https://doi.org/10.1177/1178626419875089 10.1177/1178626419875089 Yanbao Yu1, Tamara Tsitrin1, Shiferaw Bekele1, Vishal Thovarai1, Manolito G Torralba2, Harinder Singh1, Randall Wolcott3, Sebastian N Doerfert4, Maria V Sizova4 , Slava S Epstein4 and Rembert Pieper1 1J. Craig Venter Institute, Rockville, MD, USA. 2J. Craig Venter Institute, La Jolla, CA, USA. 3Southwest Regional Wound Care Center, Lubbock, TX, USA. 4Northeastern University, Boston, MA, USA. ABSTRACT: Aerococcus urinae (Au) and Globicatella sanguinis (Gs) are gram-positive bacteria belonging to the family Aerococcaceae and colonize the human immunocompromised and catheterized urinary tract. We identified both pathogens in polymicrobial urethral catheter biofilms (CBs) with a combination of 16S rDNA sequencing, proteomic analyses, and microbial cultures. Longitudinal sampling of biofilms from serially replaced catheters revealed that each species persisted in the urinary tract of a patient in cohabitation with 1 or more gram-negative uropathogens. The Gs and Au proteomes revealed active glycolytic, heterolactic fermentation, and peptide catabolic energy metabolism pathways in an anaerobic milieu. A few phosphotransferase
    [Show full text]
  • Thi Na Utaliblat in Un Minune Talk
    THI NA UTALIBLATUS010064900B2 IN UN MINUNE TALK (12 ) United States Patent ( 10 ) Patent No. : US 10 , 064 ,900 B2 Von Maltzahn et al . ( 45 ) Date of Patent: * Sep . 4 , 2018 ( 54 ) METHODS OF POPULATING A (51 ) Int. CI. GASTROINTESTINAL TRACT A61K 35 / 741 (2015 . 01 ) A61K 9 / 00 ( 2006 .01 ) (71 ) Applicant: Seres Therapeutics, Inc. , Cambridge , (Continued ) MA (US ) (52 ) U . S . CI. CPC .. A61K 35 / 741 ( 2013 .01 ) ; A61K 9 /0053 ( 72 ) Inventors : Geoffrey Von Maltzahn , Boston , MA ( 2013. 01 ); A61K 9 /48 ( 2013 . 01 ) ; (US ) ; Matthew R . Henn , Somerville , (Continued ) MA (US ) ; David N . Cook , Brooklyn , (58 ) Field of Classification Search NY (US ) ; David Arthur Berry , None Brookline, MA (US ) ; Noubar B . See application file for complete search history . Afeyan , Lexington , MA (US ) ; Brian Goodman , Boston , MA (US ) ; ( 56 ) References Cited Mary - Jane Lombardo McKenzie , Arlington , MA (US ); Marin Vulic , U . S . PATENT DOCUMENTS Boston , MA (US ) 3 ,009 ,864 A 11/ 1961 Gordon - Aldterton et al. 3 ,228 ,838 A 1 / 1966 Rinfret (73 ) Assignee : Seres Therapeutics , Inc ., Cambridge , ( Continued ) MA (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 CN 102131928 A 7 /2011 EA 006847 B1 4 / 2006 U .S . C . 154 (b ) by 0 days. (Continued ) This patent is subject to a terminal dis claimer. OTHER PUBLICATIONS ( 21) Appl . No. : 14 / 765 , 810 Aas, J ., Gessert, C . E ., and Bakken , J. S . ( 2003) . Recurrent Clostridium difficile colitis : case series involving 18 patients treated ( 22 ) PCT Filed : Feb . 4 , 2014 with donor stool administered via a nasogastric tube .
    [Show full text]